Clinicians & Researchers

You are here

Home

PETAL Network Bibliography

Export 32 results:
Author Title Type [ Year(Asc)]
2022
Valley TS, Schutz A, Peltan ID, Vranas KC, Mathews KS, Jolley SE, Palakshappa JA, Hough CL.  2022.  Organization of Outpatient Care After COVID-19 Hospitalization.. Chest.
Peltan ID, McLean SR, Murnin E, Butler AM, Wilson EL, Samore MH, Hough CL, Dean NC, Bledsoe JR, Brown SM.  2022.  Prevalence, Characteristics, and Outcomes of Emergency Department Discharge Among Patients With Sepsis.. JAMA Netw Open. 5(2):e2147882.
2021
Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al..  2021.  Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.
Iwashyna TJ, Kamphius LA, Gundel SJ, Hope AA, Jolley S, Admon AJ, Caldwell E, Monahan M, Hauschildt K, B Thompson T et al..  2021.  Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity 1 Month After Hospitalization for Third-Wave COVID-19: Early Results From a US Nationwide Cohort. Journal of Hospital Medicine.
Carlton EF, Ice E, Barbaro RP, Kampuis L, Moss M, Angus DC, Banner-Goodspeed VM, Ginde AA, Gong MN, Grissom CK et al..  2021.  Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome.. J Crit Care. 64:160-164.
Mathews KS, Seitz KP, Vranas KC, Duggal A, Valley TS, Zhao B, Gundel S, Harhay MO, Chang SY, Hough CL.  2021.  Variation in Initial U.S. Hospital Responses to the Coronavirus Disease 2019 Pandemic . Critical Care Medicine.
2020
Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR et al..  2020.  Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial . JAMA.
Hauschildt KE, Seigworth C, Kamphuis LA, Hough CL, Moss M, McPeake JM, Iwashyna TJ.  2020.  Financial Toxicity After Acute Respiratory Distress Syndrome: A National Qualitative Cohort Study.. Crit Care Med. 48(8):1103-1110.
Ginde AA, Talmor D.  2020.  High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients. Reply.. N Engl J Med. 382(17):1670-1671.
Baron RM, Christman JW, Liu KD, Matthay MA, Self WH, McVerry BJ, Hite RDuncan, Paine R, Wurfel MM, Shapiro NI et al..  2020.  Monitoring Research Blood Sampling in Critically Ill Patients: Avoiding Iatrogenic Anemia.. Am J Respir Crit Care Med. 202(6):885-887.
2019
Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, Grissom CK, Gundel S, Hayden D, R Hite D et al..  2019.  Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.. N Engl J Med. 380(21):1997-2008.
Lanspa MJ, Gong MNg, Schoenfeld DA, Lee KTiffany, Grissom CK, Hou PC, Serpa-Neto A, Brown SM, Iwashyna TJ, Yealy DM et al..  2019.  Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.. Ann Am Thorac Soc. 16(3):356-362.
2017
B Thompson T, Chamber RC, Liu KD.  2017.  Acute Respiratory Distress Syndrome. The New England Journal of Medicine. 377(6):562-572.
Thompson BT.  2017.  Acute respiratory distress syndrome in another 50 years: historical footnote or persistent malady?
Huang DT, Angus DC, Moss M, Thompson BT, Ferguson ND, Ginde A, Gong MN, Gundel S, Hayden DL, Hite RD et al..  2017.  Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
Thompson BT.  2017.  Greater Treatment Effect With Lower Disease Severity: VASST Insights.
Walkey AJ, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS, Thompson BT et al..  2017.  Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
Walkey AJ, Goligher EC, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS et al..  2017.  Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
Wei Y, Tejera P, Wang Z, Zhang R, Chen F, Su L, Lin X, Bajwa EK, Thompson BT, Christiani DC.  2017.  A Missense Genetic Variant in LRRC16A/CARMIL1 Improves Acute Respiratory Distress Syndrome Survival by Attenuating Platelet Count Decline.
Brown SM, Duggal A, Tidswell M, Khan A, Exline M, Park PK, Schoenfeld DS, Liu M, Grissom CK, Moss M et al..  2017.  Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study.. Critical Care Medicine. 45(8):1317-1324.
Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, Adhikari NKJ, Amato M, Branson R, Brower RG et al..  2017.  An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.
Aggarwal NR, Brower RG, Hager DN, Thompson BT, Netzer G, Shanholtz C, Lagakos A, Checkley W, Investigators NInstitutes.  2017.  Oxygen Exposure Resulting in Arterial Oxygen Tensions Above the Protocol Goal Was Associated with Worse Clinical Outcomes in Acute Respiratory Distress Syndrome.
Jolley SE, Hough CL, Clermont G, Hayden D, Hou S, Schoenfeld D, Smith NL, Thompson BT, Bernard GR, Angus DC et al..  2017.  Relationship between Race and the Effect of Fluids on Long-term Mortality after Acute Respiratory Distress Syndrome. Secondary Analysis of the National Heart, Lung, and Blood Institute Fluid and Catheter Treatment Trial..
Chiumello D, Brochard L, Marini JJ, Slutsky AS, Mancebo J, Ranieri VM, Thompson BT, Papazian L, Schultz MJ, Amato M et al..  2017.  Respiratory support in patients with acute respiratory distress syndrome: an expert opinion..
Meade MO, Young D, Hanna S, Zhou Q, Bachman TE, Bollen C, Slutski AS, Lamb SE, Adhikari NKJ, Mentzelopoulou SD et al..  2017.  Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome.
2016
Gong MNg, B Thompson T.  2016.  Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention. Current opinion in critical care. 22(1):21-37.
Huang DT, Angus DC, Moss M, Thompson BT, Ferguson ND, Ginde A, Gong MN, Gundel S, Hayden DL, Hite RD et al..  2016.  Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) Trial for Acute Respiratory Distress Syndrome.. Annals of the American Thoracic Society.
Benthin C, Pannu S, Khan A, Gong M.  2016.  The Nature and Variability of Automated Practice Alerts Derived from Electronic Health Records in a U.S. Nationwide Critical Care Research Network.
Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou P, B Thompson T, Brower RG.  2016.  Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among patients with Acute Respiratory Distress Syndrome.. Chest.
Sjoding MW, Schoenfeld DA, Brown SM, Hough CL, Yealy DM, Moss M, Angus DC, Iwashyna TJ, Network. NHLBIPrevention.  2016.  Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints: A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with ARDS.. Annals of the American Thoracic Society.
Beitler JR, Malhorta A, Thompson BT.  2016.  Ventilator-induced Lung Injury.
0
Berger JS, Korthblith LZ, Gong MN.  0.  Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically Ill Hospitalized Patients With COVID-19 A Randomized Clinical Trial. :227-236.